Drug Profile
Atrial natriuretic peptide - Jubilant Life Sciences
Alternative Names: Radiolabeled atrial natriuretic peptideLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Clinical Research Institute of Montreal; Hotel Dieu de Montreal
- Developer Clinical Research Institute of Montreal; DRAXIMAGE; Hotel Dieu de Montreal
- Class Peptides; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Kidney disorders
Most Recent Events
- 05 Oct 2001 Preclinical development for Kidney disorders (diagnosis) in Canada (Unknown route)